Elias Halabi

Senior Scientist, Non-Viral Delivery, Novo Nordisk

Elias A. Halabi is a Senior Scientist and Team Lead in Non-Viral Delivery at Novo Nordisk, focused on advancing gene therapies using lipid and polymer nanoparticle systems. He has 14+ years of academic and industry experience spanning ETH Zurich, Harvard Medical School, and MGH, specializing in nanoparticle engineering, translational development, and CMC-ready formulation strategies.

Seminars

Wednesday 18th November 2026
Advanced Methods for Quality & Reproducibility of Targeted LNPs
5:10 pm
  • Reveal hidden LNP heterogeneity by combining bulk and single-particle analytics to better understand composition and structure function relationships
  • Improve reproducibility and product control through advanced characterization of coupling efficiency, particle consistency, and key quality attributes
  • Accelerate translation to CMC and QC readiness by integrating high-resolution
Elias Halabi